血小板淀粉样前体蛋白是小鼠静脉血栓栓塞的调节因子
本研究利用APP基因敲除小鼠探讨淀粉样前体蛋白(APP)在止血和血栓形成中的作用。APP缺失不影响体外血小板聚集、分泌及整合素αIIbβ3活化,循环血小板数减少约20%,但动脉血栓形成正常;在静脉血栓模型中APP-KO小鼠及血液细胞选择性APP缺陷嵌合小鼠血栓更大、更易栓塞,伴APTT缩短、FXIa活性升高及血小板-白细胞聚集体增多。结果表明血小板APP通过负向调控纤维蛋白形成和中性粒细胞功能限制静脉血栓栓塞。
要点
- APP缺失不影响体外血小板聚集、分泌及整合素αIIbβ3活化,循环血小板数减少约20%。
- APP-KO小鼠动脉血栓形成正常,但静脉血栓模型中血栓更大且更易发生栓塞。
- APP-KO小鼠APTT缩短、FXIa活性升高,血小板-白细胞聚集体增多,中性粒细胞更易伸出胞外诱捕网。
核心结论
- 血小板APP通过负向调控纤维蛋白形成和中性粒细胞功能限制静脉血栓栓塞。
研究设计与样本
- 使用APP基因敲除(KO)小鼠研究APP在止血和血栓形成中的作用。
- 采用血液细胞选择性APP缺陷的嵌合小鼠进行静脉血栓模型实验。
主要发现
- APP缺陷血小板体外由多种激动剂诱导的聚集、分泌及整合素αIIbβ3由内向外活化正常,但循环血小板数减少约20%,体积轻度增大。
- APP-KO小鼠尾出血时间正常,体内股动脉血栓形成未改变。
- 下腔静脉血流限制诱导的静脉血栓模型中,APP-KO小鼠及血液细胞选择性APP缺陷嵌合小鼠血栓较对照动物更大,且更易发生栓塞。
- 肺血栓栓塞模型中,APP-KO小鼠较大血管被闭塞。
- 在有血小板存在时,APP-KO小鼠APTT缩短而PT未变;APP-KO小鼠FXIa活性较对照升高,FXIIa活性未升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The amyloid precursor protein (APP), primarily known as the precursor of amyloid peptides that accumulate in the brain of patients with Alzheimer disease, is abundant in platelets, but its physiological function remains unknown. In this study, we investigated the role of APP in hemostasis and thrombosis, using APP knockout (KO) mice. Ex vivo aggregation, secretion, and integrin αIIbβ3 inside-out activation induced by several agonists were normal in APP-deficient platelets, but the number of circulating platelets was reduced by about 20%, and their size was slightly increased. Tail bleeding time was normal, and in vivo, the absence of APP did not alter thrombus formation in the femoral artery. In contrast, in a model of vein thrombosis induced by flow restriction in the inferior vena cava, APP-KO mice, as well as chimeric mice with selective deficiency of APP in blood cells, developed much larger thrombi than control animals, and were more sensitive to embolization. Consistent with this, in a pulmonary thromboembolism model, larger vessels were occluded. APP-KO mice displayed a shorter APTT, but not PT, when measured in the presence of platelets. Moreover, the activity of factor XIa (FXIa), but not FXIIa, was higher in APP-KO mice compared with controls. APP-KO mice presented a higher number of circulating platelet-leukocyte aggregates, and neutrophils displayed a greater tendency to protrude extracellular traps, which were more strongly incorporated into venous thrombi. These results indicate that platelet APP limits venous thromboembolism through a negative regulation of both fibrin formation and neutrophil function.
引用
- Canobbio I, Visconte C, Momi S, et al. Platelet amyloid precursor protein is a modulator of venous thromboembolism in mice. Blood. 2017. PMID: 28611024. doi:10.1182/blood-2017-01-764910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。